John Seiler, MD
Hand Surgery · Atlanta, GANPI 1982620456
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $963 of the $1,148 with a category attached, or 83.8%. Axogen accounts for 83.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $963 and has fallen 96.2% since, to $37 in 2024. That places this record below the midpoint for hand surgery clinicians in GA, where the typical reported total is $1,780.
Across 7 payments — averaging $164.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$963
- United Orthopedics LLC$77
- Zimmer Biomet$31
- Axonics, Inc.$24
- Bioventus LLC$20
- Johnson & Johnson$17
- plus $17 from 1 others
Across 6 payments — averaging $3468.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$21K
What the payments were for
- Speaking & faculty fees$96384%
- Food & beverage$18616%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 1 | $963 |
| United Orthopedics LLC | 1 | $77 |
| Zimmer Biomet | 1 | $31 |
| Axonics, Inc. | 1 | $24 |
| Bioventus LLC | 1 | $20 |
| Johnson & Johnson | 1 | $17 |
| Ossur Americas, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,148 in reported general payments places this provider in the 30th percentile of 77 hand surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 134 | $2,863 |
| Methylprednisolone | 62 | $378 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 86 | $364 |
| Meloxicam | 81 | $195 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Atlanta
- Eric WagnerAtlanta$173K
- Phani DantuluriAtlanta$120K
- Travis LittletonAtlanta$35K
- Nicole ZelenskiAtlanta$34K
- James SprattAtlanta$18K
- Jim RoderiqueAtlanta$14K
- Bryce GillespieAtlanta$10K
- Andy ChangAtlanta$7K
- Randall AlexanderAtlanta$7K
- Catphuong VuAtlanta$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.